The dominant role of proofreading exonuclease activity of replicative polymerase ε in cellular tolerance to cytarabine (Ara-C)

29Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Chemotherapeutic nucleoside analogs, such as Ara-C, 5-Fluorouracil (5-FU) and Trifluridine (FTD), are frequently incorporated into DNA by the replicative DNA polymerases. However, it remains unclear how this incorporation kills cycling cells. There are two possibilities: Nucleoside analog triphosphates inhibit the replicative DNA polymerases, and/or nucleotide analogs mis-incorporated into genomic DNA interfere with the next round of DNA synthesis as replicative DNA polymerases recognize them as template DNA lesions, arresting synthesis. To address the first possibility, we selectively disrupted the proofreading exonuclease activity of DNA polymerase ε (Polε), the leading-strand replicative polymerase in avian DT40 and human TK6 cell lines. To address the second, we disrupted RAD18, a gene involved in translesion DNA synthesis, a mechanism that relieves stalled replication. Strikingly, POLE1exo-/- cells, but not RAD18-/- cells, were hypersensitive to Ara-C, while RAD18-/- cells were hypersensitive to FTD. γH2AX focus formation following a pulse of Ara-C was immediate and did not progress into the next round of replication, while γH2AX focus formation following a pulse of 5-FU and FTD was delayed to the next round of replication. Biochemical studies indicate that human proofreading-deficient Pole-exoholoenzyme incorporates Ara-CTP, but subsequently extend from this base several times less efficiently than from intact nucleotides. Together our results suggest that Ara-C acts by blocking extension of the nascent DNA strand and is counteracted by the proofreading activity of Pole, while 5-FU and FTD are efficiently incorporated but act as replication fork blocks in the subsequent S phase, which is counteracted by translesion synthesis.

References Powered by Scopus

Multiplex genome engineering using CRISPR/Cas systems

12182Citations
N/AReaders
Get full text

RNA-guided human genome engineering via Cas9

7515Citations
N/AReaders
Get full text

5-Fluorouracil: Mechanisms of action and clinical strategies

4239Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Nucleobase and nucleoside analogues: Resistance and re-sensitisation at the level of pharmacokinetics, pharmacodynamics and metabolism

97Citations
N/AReaders
Get full text

Chemical methods for the modification of RNA

74Citations
N/AReaders
Get full text

Adjuvant treatment for POLE proofreading domain–mutant cancers: Sensitivity to radiotherapy, chemotherapy, and nucleoside analogues

68Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tsuda, M., Terada, K., Ooka, M., Kobayashi, K., Sasanuma, H., Fujisawa, R., … Hirota, K. (2017). The dominant role of proofreading exonuclease activity of replicative polymerase ε in cellular tolerance to cytarabine (Ara-C). Oncotarget, 8(20), 33457–33474. https://doi.org/10.18632/oncotarget.16508

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

59%

Professor / Associate Prof. 4

24%

Researcher 2

12%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 17

74%

Agricultural and Biological Sciences 3

13%

Medicine and Dentistry 2

9%

Pharmacology, Toxicology and Pharmaceut... 1

4%

Save time finding and organizing research with Mendeley

Sign up for free